K L Woods|S Fletcher - JoVE Visualize

Showing results (511-520 of 632) with videos related to

Pageof 64

Sort By:

Oncogene|December 14, 2018

STAT3 inhibition reduces macrophage number and tumor growth in neurofibromaJonathan S Fletcher, Mitchell G Springer, Kwangmin Choi, et al.

Transfusion|May 3, 2020

A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an optionMarc Zumberg, Jed Gorlin, Elizabeth A Griffiths, et al.

Cancer|November 15, 1986

A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.

Cell|May 19, 1995

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseJ D MacMicking, C Nathan, G Hom, et al.

Journal of Surgical Oncology|January 1, 1976

A randomized pilot study comparing two regimens in the treatment of squamous cell carcinomaH S Moseley, T Sasaki, D B McConnell, et al.

Journal of Surgical Oncology|January 1, 1979

5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230A Awrich, W S Fletcher, J H Klotz, et al.

International Journal of Psychiatry in Medicine|April 24, 2021

FACT effectiveness in primary care; a single visit RCT for depressive symptomsB Arroll, H Frischtak, R Roskvist, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000

Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.

Cancer|August 27, 1999

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trialC G Leichman, J R Jacobson, M Modiano, et al.

The American Journal of Gastroenterology|February 1, 1990

Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with SandostatinE J Mozell, E A Woltering, T M O'Dorisio, et al.

Pageof 64

Showing results (511-520 of 632) with videos related to

Sort By:

Pageof 64

Oncogene|December 14, 2018

STAT3 inhibition reduces macrophage number and tumor growth in neurofibromaJonathan S Fletcher, Mitchell G Springer, Kwangmin Choi, et al.

Transfusion|May 3, 2020

A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an optionMarc Zumberg, Jed Gorlin, Elizabeth A Griffiths, et al.

Cancer|November 15, 1986

A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.

Cell|May 19, 1995

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseJ D MacMicking, C Nathan, G Hom, et al.

Journal of Surgical Oncology|January 1, 1976

A randomized pilot study comparing two regimens in the treatment of squamous cell carcinomaH S Moseley, T Sasaki, D B McConnell, et al.

Journal of Surgical Oncology|January 1, 1979

5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230A Awrich, W S Fletcher, J H Klotz, et al.

International Journal of Psychiatry in Medicine|April 24, 2021

FACT effectiveness in primary care; a single visit RCT for depressive symptomsB Arroll, H Frischtak, R Roskvist, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000

Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.

Cancer|August 27, 1999

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trialC G Leichman, J R Jacobson, M Modiano, et al.

The American Journal of Gastroenterology|February 1, 1990

Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with SandostatinE J Mozell, E A Woltering, T M O'Dorisio, et al.

Pageof 64